Louis Moore Bacon's TEVA Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 165.2K shares of Teva Pharmaceutical Industries Limited (TEVA) worth $3.34 M, representing 0.05% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Louis Moore Bacon has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2020, adding 1.1M shares. Largest reduction occurred in Q3 2025, reducing 934.8K shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +180,000 | New Buy | 180,000 | $57.51 |
| Q1 2015 | -180,000 | Sold Out | 180,000 | $0.00 |
| Q4 2015 | +31,994 | New Buy | 31,994 | $65.64 |
| Q1 2016 | -31,994 | Sold Out | 31,994 | $0.00 |
| Q1 2020 | +1.1 M | New Buy | 1.1 M | $8.98 |
| Q2 2020 | -1.1 M | Sold Out | 1.1 M | $0.00 |
| Q3 2025 | +165,197 | New Buy | 165,197 | $20.20 |
Louis Moore Bacon's Teva Pharmaceutical Industries Limited Investment FAQs
Louis Moore Bacon first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q4 2014, acquiring 180,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Teva Pharmaceutical Industries Limited (TEVA) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q1 2020, adding 1,100,000 shares worth $9.88 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 165,197 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $3.34 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.05% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 1,100,000 shares, as reported at the end of Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.